Picture of Zhaoke Ophthalmology logo

6622 — Zhaoke Ophthalmology News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Zhaoke Ophthalmology Obtains Marketing Authorization For Bimatoprost Timolol Eye Drop

Feb 20 (Reuters) - Zhaoke Ophthalmology Ltd  6622.HK :
    * MARKETING AUTHORIZATION FOR BIMATOPROST TIMOLOL EYE DROP
OBTAINED FROM NATIONAL MEDICAL PRODUCTS ADMINISTRATION

Further company coverage:  6622.HK 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Zhaoke Ophthalmology

See all news